找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Virus Entry Inhibitors; Stopping the Enemy a Shibo Jiang,Lu Lu Book 2022 The Editor(s) (if applicable) and The Author(s), under exclusive l

[復(fù)制鏈接]
樓主: ACRO
31#
發(fā)表于 2025-3-27 00:45:04 | 只看該作者
32#
發(fā)表于 2025-3-27 03:57:32 | 只看該作者
Endogenous Peptide Inhibitors of HIV Entry,SDF-1/CXCL12 inhibits specific viral strains. The knowledge that RANTES, MlP-1α, and MlP-1β specifically inhibit other primary HIV-1 strains allowed the rapid discovery of CCR5 as second major viral coreceptor and explained why individuals with deletions in CCR5 are protected against sexual HIV-1 tr
33#
發(fā)表于 2025-3-27 09:13:41 | 只看該作者
34#
發(fā)表于 2025-3-27 12:40:39 | 只看該作者
35#
發(fā)表于 2025-3-27 14:40:56 | 只看該作者
36#
發(fā)表于 2025-3-27 21:40:42 | 只看該作者
Broad-spectrum Respiratory Virus Entry Inhibitors,ile more than 260 viruses are known to infect humans, only a small minority of these viral diseases are treatable by clinically approved antiviral drugs. Apart from these identified viruses, new emerging viruses and drug-resistant viruses are also important challenges to our public health and health
37#
發(fā)表于 2025-3-27 22:46:06 | 只看該作者
Ebola Virus Entry Inhibitors,ugh two monoclonal antibody (mAb) drugs have recently received approval in the USA, additional therapeutics are still needed to combat potential outbreaks of resistance variants and other closely related ebola viruses. In this chapter, we describe the current understanding of the EBOV entry process
38#
發(fā)表于 2025-3-28 03:04:38 | 只看該作者
39#
發(fā)表于 2025-3-28 07:45:18 | 只看該作者
Entry Inhibitors of Hepatitis B and D Viruses, the major cause of chronic hepatitis, liver failure, cirrhosis, and hepatocellular carcinoma (HCC). In nature, HBV and HDV have a narrow host range and highly hepatotropic, only infecting the hepatocytes of humans and a few primates. The elucidation of cell entry mechanism by HBV has made great pro
40#
發(fā)表于 2025-3-28 13:13:21 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-16 07:23
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
师宗县| 黎平县| 琼结县| 桑植县| 淳安县| 昌图县| 许昌县| 阜阳市| 名山县| 广南县| 望奎县| 马尔康县| 凌云县| 泸西县| 定襄县| 宿州市| 交城县| 巨鹿县| 商都县| 龙游县| 即墨市| 巴林右旗| 宜城市| 长汀县| 逊克县| 吉林省| 涞水县| 当涂县| 疏勒县| 苏尼特右旗| 青铜峡市| 札达县| 四川省| 杭州市| 博野县| 阳新县| 五华县| 浦北县| 禹城市| 垣曲县| 长乐市|